Details for New Drug Application (NDA): 090794
✉ Email this page to a colleague
The generic ingredient in ESTARYLLA is ethinyl estradiol; norgestimate. There are twenty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestimate profile page.
Summary for 090794
Tradename: | ESTARYLLA |
Applicant: | Xiromed |
Ingredient: | ethinyl estradiol; norgestimate |
Patents: | 0 |
Suppliers and Packaging for NDA: 090794
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ESTARYLLA | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 090794 | ANDA | Par Pharmaceutical, Inc. | 0254-2029 | 0254-2029-91 | 1 BLISTER PACK in 1 CARTON (0254-2029-91) / 1 KIT in 1 BLISTER PACK |
ESTARYLLA | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 090794 | ANDA | AvKARE | 42291-553 | 42291-553-84 | 3 CARTON in 1 CARTON (42291-553-84) / 1 BLISTER PACK in 1 CARTON (42291-553-28) / 1 KIT in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL-28 | Strength | 0.035MG;0.25MG | ||||
Approval Date: | Jan 30, 2013 | TE: | AB | RLD: | No |
Complete Access Available with Subscription